We are pleased to publish the Health~Holland Year in Review 2015, our yearly magazine that brings you the developments from Top Sector Life Sciences & Health in 2015.
Polyganics, a privately held medical technology company focused on the commercialization of proprietary products and technologies for peripheral nerve repair, neurosurgery, general surgery, as well as ear, nose & throat surgery, announced it has received FDA 510,000 euros clearance for NEUROCAP, an innovative device designed to reduce painful neuroma formation and thereby facilitate tissue repair and regeneration.
Leiden-based biotechnology company Mimetas has received 1.6 million USD funding for development of an organ-on-a-chip model for neurotoxicity. The aim of the project is to improve existing neurotoxicity tests and to reduce experimentation on animals.
Agendia, Inc. and several European partners have received a $6.8 million European Commission grant to study targeted therapies for colorectal cancer (CRC). The grantees will test therapies matched to the molecular subtype of each patient’s tumor, to see if they are more effective than current therapies not keyed to a tumor’s subtype.
Samenwerking Topsectoren Creatieve Industrie en Life Sciences & Health levert 1,4 miljoen op voor onderzoek naar zelfstandigheid bij dementie. Twee grootschalige projecten met de namen FIT en Roodkapje maken aanspraak op de subsidie.
Frank Meijer, medeoprichter van Platform Congenitale Hernia Diafragmatica (CHD) en onderzoeker dr. Sanne Botden van het RadboudUMC kregen de Medische Inspirator uitgereikt door juryvoorzitter Elizabeth Vroom voor hun onderzoek naar CHD.
Treeway, a biotech company developing therapies against amyotrophic lateral sclerosis (ALS), announced the completion of two successful phase I trials with their lead compound TW001, a new more patient friendly oral formulation of the Japanese stroke and ALS therapy edaravone.
